Parameter | 2019 (pre-pandemic period) | 2020 (pandemic period) | P value | |
---|---|---|---|---|
Total/mean (patient-days) | 74.012/10.16 | 72.742/9.2 | ||
Age (years) gender (male%) | 8146.5% | 7948.5% | ||
Incidence CDI/10 000 patient-days | 6.35 | 2.47 | RR= 0.39, p<0.001 | |
Antibiotic consumption DDD/ 100 patient-days | ||||
Ceftriaxone | 11.68 | 21.75 | p<0.01 | |
Amoxicillin/clavulanic | 14.96 | 10.44 | p<0.01 | |
Quinolones | 13.67 | 9.07 | p<0.01 | |
Carbapenems | 4.39 | 4.48 | p=0.4 | |
Piperacilin/tazobactam | 5.13 | 4.71 | p<0.01 | |